10 Regeneron regulatory affairs leaders
VP, Regulatory Affairs Regeneron, Executive Director of CMC Regulatory Affairs and Director, Global Regulatory Strategy are among the current titles held by these Regeneron regulatory affairs leaders. A reader can learn how regulatory affairs leaders work at Regeneron from people who have held the role.
Professionals to explore
Boning Zhao, PharmD
LinkedInExperience: Director, Global Regulatory Strategy · Regeneron
Boning Zhao has been Director, Global Regulatory Strategy at Regeneron since September 2026, based in the New York City Metropolitan Area. At Regeneron, Boning Zhao was Associate Director, Global Regulatory Strategy from 2024 to 2026, Senior Manager, Global Regulatory Strategy from 2023 to 2024 and Manager, Global Regulatory Strategy in 2022.
Brian Baker
LinkedInExperience: Executive Director, Regulatory Affairs (in Vitro Diagnostics) · Regeneron
Brian Baker has been Executive Director, Regulatory Affairs (in Vitro Diagnostics) at Regeneron since January 2024 and was Sr. Director, Regulatory Affairs (CDx) there from 2020 to 2023, based in the Dallas-Fort Worth Metroplex. Brian Baker was Sr. Director, Project Management at Caris Life Sciences from 2019 to 2020 and Director, Regulatory Affairs - Companion Diagnostics (CDx) at Roche from 2017 to 2018.
Edward Cox
LinkedInExperience: Vice President Regulatory Affairs · Regeneron
Edward Cox has been Vice President Regulatory Affairs at Regeneron since August 2019, based in the Washington DC-Baltimore Area. At U.S. Food and Drug Administration, Edward Cox was Director, Office of Antimicrobial Products from 2007 to 2019 and Deputy Director, Office of Antimicrobial Products from 2003 to 2007, and the profile says Edward Cox is trained in internal medicine and infectious diseases.
Elisa Babilonia
LinkedInExperience: VP, Regulatory Affairs Regeneron · Regeneron
Elisa Babilonia has been VP, Regulatory Affairs Regeneron at Regeneron since December 2025, based in the New York City Metropolitan Area. At Regeneron, Elisa Babilonia held the titles Executive Director Regulatory Affairs from 2022 to 2025 and Senior Director Regulatory Affairs from 2020 to 2022, and the listing also shows rows titled Director and Associate Director, Regulatory Affairs at Regeneron.
Gianina Meltzer, PhD
LinkedInExperience: Senior Director, Regulatory Affairs · Regeneron
Gianina Meltzer has been Senior Director, Regulatory Affairs at Regeneron since January 2026 and was Director, Regulatory Affairs (Oncology) there from 2022 to 2025, based in Summit, New Jersey. Gianina Meltzer was Director, Regulatory Affairs (Oncology) at Celularity Inc. from 2021 to 2022 and Global Regulatory Lead - Imuno-Oncology, Late Stage Clinical Development at Bristol Myers Squibb from 2019 to 2021.
Matt Campagna
LinkedInExperience: Director, Regulatory Affairs CMC · Regeneron
Matt Campagna has been Director, Regulatory Affairs CMC at Regeneron since April 2026, based in the New York City Metropolitan Area, and the profile describes the role as team lead for CMC regulatory strategy. Matt Campagna was Associate Director, Regulatory Affairs CMC at Daiichi Sankyo from 2020 to 2022 and Senior Manager, Regulatory Affairs CMC at Viela Bio from 2019 to 2020.
Paria Saunders, PhD, PMP, RAC
LinkedInExperience: Director, Global Regulatory Affairs- Oncology · Regeneron
Paria Saunders has been Director, Global Regulatory Affairs- Oncology at Regeneron since July 2025, based in the New York City Metropolitan Area. At Regeneron, Paria Saunders was Director, Development Program Management- Oncology from 2022 to 2025 and Associate Director, Development Program Management in 2022, and was Global Project Manager, New Drug Development at Indivior from 2018 to 2020.
Shazia Ali
LinkedInExperience: Senior Director Regulatory Affairs · Regeneron
Shazia Ali has been Senior Director Regulatory Affairs at Regeneron since August 2022, based in Fair Lawn, New Jersey. At Regeneron, Shazia Ali was Senior Director, Early Clinical Development from 2021 to 2022, Director, Global Clinical Development from 2019 to 2021 and Associate Director, Clinical Sciences from 2016 to 2018.
Sumana Biswas, Ph.D.
LinkedInExperience: Executive Director Regulatory Affairs Strategy · Regeneron
Sumana Biswas has been Executive Director Regulatory Affairs Strategy at Regeneron since May 2025, based in the New York City Metropolitan Area. The listing also shows Sumana Biswas as US Group Head, Regulatory Affairs Strategy, Cardio-Renal at Bayer from 2019, and as Global Program Assoc. Director, Drug Regulatory Affairs at Novartis from 2015 to 2019.
Zhenzhen Liu
LinkedInExperience: Executive Director of CMC Regulatory Affairs · Regeneron
Zhenzhen Liu has been Executive Director of CMC Regulatory Affairs at Regeneron since January 2026, based in Gaithersburg, Maryland. At Regeneron, Zhenzhen Liu was Senior Director of CMC Regulatory Affairs from 2024 to 2026 and Director of CMC Regulatory Affairs from 2022 to 2023, and was Product Quality (CMC) Team Leader at FDA from 2019 to 2022.
Choose the right perspective
Match the scope in a person's title, such as regulatory strategy, regulatory CMC or in vitro diagnostics, to the question you need answered. Weigh how recently each person held the role and whether a director-level or executive-level view fits your question better.
Questions to take into the conversation
- 01What did you focus on first when you took on your regulatory affairs role at Regeneron?
- 02What has changed in how you approach regulatory work since you took on your current role?
- 03What has your own work at Regeneron taught you about building a regulatory affairs team?
Reaching Regeneron regulatory affairs leaders
How can I contact one of these Regeneron regulatory affairs leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Regeneron, based on profile data retrieved on October 24, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Regeneron regulatory affairs leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Regeneron regulatory affairs leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal